Average Cost of Cardiovascular Disease Treatment in ...

Conventional Heart Bypass Surgery, S$6,966, S$36,682, S$75,398 ; Data Source: Ministry of Health ... CardiovasculardiseaseistheleadingkillerinSingapore,accountingfor1in3deaths.Cardiovasculardiseaseencompasseseverythingfromheartpalpitationstocardiacarrestandstroke,meaningthattreatmentcanrangefromsimpleandaffordablemedicationtocomplexandexpensivesurgeries.Below,webreakdownthecostofcardiovasculartreatmentsandsurgeriesbasedondiseasecategoryandhospitaltype. TableofContents AverageCostofIschaemicHeartDiseaseTreatment CostofHeartDiseaseMedication AverageCostofCerebrovascularDiseaseTreatment AverageCostofArrhythmiaTreatment HowtoPayforTreatment AverageCostofIschaemicHeartDiseaseTreatment Theaveragebillsizeofgettingtreatmentforischaemicheartdisease-relatedillnessescostsS$2,944atapublicsubsidisedward,S$11,618atapublicunsubsidisedwardandS$24,149ataprivatehospital.Ischaemicheartdisease(alsoknownascoronaryarterydisease)canleadtoheartattacks,heartfailure,chestpainandcardiacarrest.Proceduresforthesedisordersincludeeverythingfromexaminationofchestpaintoheartbypasssurgery.Asexpected,thecostforsimpleproceduressuchaschestpainorhighbloodpressuretreatmentisfairlylow,averaginglessthanS$700atapublicsubsidisedward.However,complicatedproceduressuchasheartattacktreatmentandbypasssurgerycanleavepatientswithbillsintheseveralthousands.Forinstance,heartbypasssurgeryinapublicsubsidisedwardhasamedianbillofS$6,966,withtheaveragecostincreasingtoS$75,398inprivatehospitals. MedianBillSizeforIschaemicHeartDiseaseTreatment ProcedurePublicSub.PublicUnsub.PrivateAdmissionforHighBloodPressureS$614S$1,956S$4,751AdmissionforChestPain(NoComplications)S$677S$1,912S$5,895HeartFailure(NoComplications)S$1,113S$3,355S$7,708HeartAttack(NoComplications)S$1,293N/AN/AHeartAngiography(Overnight)S$2,045S$6,011S$8,718PTCA(NoHeartAttack)S$6,437S$20,914S$36,017HeartAttack(w/PTCA)S$6,308S$17,258S$40,201ConventionalHeartBypassSurgeryS$6,966S$36,682S$75,398DataSource:MinistryofHealth CostofHeartDiseaseMedication Highbloodpressureorhighcholesteroliseitherariskfactororasymptomofheartdisease.Thus,yourdoctormayprescribemedicationtotreattheseconditionstopreventyourconditionfromworsening.Theaveragecostofgenerichypertension(highbloodpressure)medicationrangesfromS$0.26perpilltoS$0.46perpill.Generichypertensionmedicationstypicallycost75%lessthanbrandedmedicationbutprovidethesameeffectiveness,thusbeingagoodoptionforbudget-constrainedpatients.Themostexpensivetypesofhighbloodpressuremedicationaretabletscontainingbothcalciumchannelblockerandstatinmedications(e.g.Caduet).Thesetypesofmedicationstreathighbloodpressure,heartpainandlowerbloodpressure.TheyhaveanaveragecostrangingbetweenS$4.17andS$4.65perpill. AverageCostofHighBloodPressureMedication(PerTablet/Capsule/Sachet) MedicationClassLow-EndPriceHigh-EndPriceACEInhibitorsS$0.25S$2.00ATIIReceptorBlockersS$1.40S$2.34ATIIReceptorBlockers&DiureticsS$2.11S$2.34BetaBlockersS$0.84S$1.05BetaBlockers&CalciumChannelBlockersS$1.48S$1.62BetaBlockers&DiureticsS$1.41S$1.52CalciumChannelBlockersS$1.45S$1.66CalciumChannelBlockers&DiureticsS$4.17S$4.65DiureticS$0.59S$0.75ReninInhibitorsS$2.72S$3.08Other(Alpha-1Blocker,Alpha-2-Agonist,etc.)S$0.61S$0.77DataSource:PharmaceuticalSocietyofSingapore Similarly,hyperlipidemia(highbloodcholesterol)medicationisanotherformoftreatmentusedfortreatingsymptomsorreducingtheriskofischaemicheartdisease.TheaveragepriceforgenerichyperlipidemiamedicationrangesfromS$2.70toS$3.05perpill.Brandedmedicationscostanaverageof1.4timesmorethangenericversions.StatinmedicationssuchasCrestor,arethemostcommontypeofcholesterolmedicationinSingapore.Theyarealsothemostexpensive,withanaveragecostbetweenS$3.93andS$4.44perpill.Fibratemedications,suchasLipofen,arethecheapesttypeofcholesterolmedicationandhaveanaveragepricerangebetweenS$1.41andS$1.69perpill.Fibratesaregiventopatientswhocan'ttakestatinmedications.WhiletheyarelesseffectivethanstatinsinloweringLDLcholesterol(badcholesterol)levels,theyarebetterthanmoststatinsinraisingHDLcholesterol(goodcholesterol). AverageCostofCholesterolMedication(PerTablet/Capsule/Sachet) MedicationClassLow-EndPriceHigh-EndPriceFibratesS$1.41S$1.58NicotinicAcidS$1.58S$1.78StatinS$3.93S$4.44Statin&CalciumChannelBlockersS$4.17S$4.65DataSource:PharmaceuticalSocietyofSingapore AverageCostofCerebrovascularDiseaseTreatment TheaveragebillsizeofcerebrovasculardiseasetreatmentcostsS$2,764atpublicsubsidisedwards,S$7,882atpublicunsubsidisedwardsandS$16,976atprivatehospitals.Themostcommonconditionthatfallsundercerebrovasculardiseaseisstroke.Asexpected,treatmentwillbemoreexpensiveifthestrokecomeswithcomplicationsorifcomorbidityispresent(strokeandotherconditionsaffectingthepatientatthesametime).Wefoundthatstroketreatmentwithminorcomplicationscosts31-36%morethanstroketreatmentwithnocomplicationsinpublichospitals.However,thiscostcanincreaseby80%ifthecomplicationsendupbeingserious.Thecostoftreatingastrokewithcomplicationsisevengreaterinprivatehospitals.Forinstance,wefoundthattreatmentforastrokewithminorcomplicationswillcostpatients145%morethantreatmentforastrokewithoutanycomplicationsinthesamehospitals. MedianBillSizeforCerebrovascularDiseaseTreatment ProcedurePublicSub.PublicUnsub.PrivateStroke(NoComplications)S$1,787S$4,902S$9,836Stroke(w/Complications)S$2,342S$6,681S$24,116Stroke(SeriousComplications)S$4,162S$12,060N/ADataSource:MinistryofHealth AverageCostofArrhythmiaTreatment Theaveragecosttotreatarrhythmias,suchasirregularheartbeatsandheartpalpitationsisS$3,415atapublicsubsidisedwards,S$13,744atpublicunsubsidisedwardsandS$16,279atprivatehospitals.Typically,routinetreatmentforheartpalpitationsandirregularheartbeatdoesn'tcostmorethanS$2,400atapublichospital.However,ifyourarrhythmiadoesn'trespondtotraditionalmedication,treatmentcangetquitecostly.ThemedianbilltotreatanirregularheartrhythmbyburninghearttissuecostsS$5,959inapublicsubsidisedward,S$25,132inanunsubsidisedwardandS$28,660inaprivatehospital. MedianBillSizeforArrhythmia&SimilarConditionTreatment ProcedurePublicSub.PublicUnsub.PrivateHeartPalpitationTreatment^S$536N/AS$5,592TreatmentforIrregularHeartRhythm,LackofHeartbeatS$871S$2,356S$4,798BurningofHeartTissueS$5,959S$25,132S$28,660^2017FiguresDataSource:MinistryofHealth AverageCostofCardiovascularTreatmentbyHospitalWard TheaveragecostoftreatingaheartconditionasaninpatientcostsS$2,929inapublicsubsidisedward.Publicunsubsidisedwardscost2.82timesmorethanpublicsubsidisedwards.Privatehospitaltreatmentcoststwicecomparedtotreatmentinpublicunsubsidisedwardsand5timesmoretreatmentinpublicsubsidisedwards.TheaveragecostofdaysurgeryforroutineischaemicheartdiseasetreatmentordiagnosisisS$3,922inpublicsubsidisedwards.Daysurgeryatapublicunsubsidisedwardcosts2.25timesasmuch,withthemedianbillsizebeingS$12,767. HowtoPayforCardiovascularDiseaseTreatment Paymentforcardiovasculardiseasetreatmentcanbecomeexpensivesinceheartconditionscanbecomechronicandmayrequireconstantcheck-upsandmedication.Youcanuseavarietyofwaystopayforyourtreatment.ThefirstisusingMedisave.YoucanwithdrawuptoS$450perdayfordailyhospitalchargesandbetweenS$250andS$7,550forinpatientanddaysurgery.Theamountyoucanwithdrawforsurgeriesdependsonthecomplexityoftheprocedure.Next,youcanuseyourMediShieldLifeplan.ItcoversuptoS$700perdayfornormalandS$1,200forintensivecareunitwardstaysperday. YoucanalsouseIntegratedShieldPlans,whichareprivatehealthinsurancesupplementstoMediShieldLife.Avarietyofinsurersofferthembutbenefitsarefairlystandardacrosstheboardandcanprovidefullcoverage(withtheexceptionofdeductibleandco-insurance)foryourhospitalstay.ThismethodofpaymentcanbebeneficialtoindividualswhoprefertostayinB1orAwards,orprivatehospitals.However,premiumswillincreaseasyouage,soyoushouldalwaysmakesureyoucanaffordyourpremiumpaymentsbeforesettlingonaplan.Furthermore,itisalsorecommendedtobuyaplanbeforeyoudevelopanytypeofheart-relatedchroniccondition,asitmayfallunderthecategoryofapre-existingcondition.Thiscanleadtohighpremiumsorexclusionsofcoverage. Iftheremainingbillisstilltoomuchforyoutoafford,thenyoumaygetadditionalhelpviaMediFund.MediFundactsasagovernmentsafetynetforpatientswhocannotaffordtopaytheremainderoftheirbillsafterusingMedishieldLifeandMedisave.However,youshouldnotethatinordertoreceiveMediFundassistance,youmusthavereceivedtreatmentfromaMediFund-approvedinstitution.Furthermore,youcanalsotrytonegotiatewiththehospitalifyouhaveclosetotheamountrequiredorseeifyoucanpayininterest-freeinstalments. Ifyoumustresorttoborrowingmoneythenyoucanconsidertakingoutapersonalloan.Youshouldlookforaloanthathaslowinterestratestoreducetheamountofinterestyou'llpayovertime.Youshouldalsomakesureyouborrowonlyfromalicensedmoneylendertoavoidpayingpredatoryinterestrates,hiddenfees.Youalsowon'tbesubjectedtopotentialharassmentthattypicallycomeswithpredatorymoneylenders. Methodology TofindtheaveragecostofcardiovasculardiseasetreatmentinSingapore,welookedatthemedianbillsizeforavailablerelevantprocedures.Webrokedowntheproceduresbasedonthetypeofheartcondition(i.e.ischaemicvs.cerebrovascularvs.heartabnormalities).ThenwelookedatthemedianbillsizebasedonthetypeofhospitalwardtofigureouthowthepricechangesamongthetypesofmedicalfacilitiesavailabletoSinagporeans.Lastly,wealsowantedtotakealookathowmuchmedicationcosts.Takingmedicationismorecommonthangettingopensurgeries,thuswefeltitwouldberelevanttoSingaporeanswhoaresufferingfromsymptomsbutmaynotneedsurgery.UsingdatafromthePharmaceuticalSocietyofSingapore,welookedatthepricingavailableforhighbloodpressureandcholesterolmedicationsandseparatedthemintotheirvariousclassestofindouthowpricingchangesbasedontypeofmedication. Pleasenotethefiguresshownhereshouldbeusedforeducationalpurposesandaresubjecttochange.Yourtreatmentmayendupcostingmoreorlessthantheaveragesshownherebasedonthespecifictreatmentneededandyourinsurance. AnastassiaEvlanova AnastassiaisaSeniorResearchAnalystatValueChampionSingapore,evaluatinginsuranceproductsforconsumersbasedonquantitativeandqualitativefinancialanalysis.SheholdsdegreesinEconomicsandInternationalBusinessManagementandherpriorworkingexperienceincludesworkinthecapitalmarketssector.Heranalysessurroundinginsurance,healthcare,internationalaffairsandpersonalfinancehasbeenfeaturedonAsiaOne,BusinessInsider,DW,Vice,HerWorld,AsiaInsuranceReview,theAustralianInstituteofInternationalAffairsandmore. OurTopPicks BestHealthInsurance BestInternationalHealthInsurance BestCriticalIllnessInsurance BestInsuranceforCOVID-19Coverage BestCareShieldLifeSupplementPlans HealthInsuranceReviews IncomeIncomeShieldHealthInsurance GreatEasternSupremeHealthHealthInsurance PrudentialPruShieldHealthInsurance AvivaMyShieldHealthInsurance FWDInternationalHealthInsurance CignaGlobalHealthInsurance AvivavsPrudentialHealthInsurance:WhichOneIsBetterForYou? Keepupwithournewsandanalysis.Stayuptodate.Subscribe {"endpoint":"\/newsletter\/subscribe","style":"blue","title":"Keepupwithournewsandanalysis.","version":"sidebar"} HealthInsuranceBasics AverageCostsandBenefitsofHealthInsurance HowtoFindtheBestHealthInsurance GuidetoIntegratedShieldPlanRiders GuidetoMediShieldLife HowtoFindtheBestHospitalinSingapore AverageCostofCancerTreatment AverageCostofCardiovascularDiseaseTreatment AverageCostofPregnancyinSingapore HowtoChooseBetweenA&Eor24-HourClinic HowtoSuccessfullyFileanInsuranceClaim RelatedArticles IntegratedShieldPlans(IP)inSingapore:WhatAreThey? ABite-SizedFinancialGuideToChildren'sDentalHygiene HowMuchWillFoodPoisoningCostYou? NeedCounselling?FreeAndAffordableMentalHealthcareResourcesInSingapore 5EasyandAffordableWaystoReduceNeckandBackPain 5MedicalExpensesThatCouldOccurinYourChild'sFirstSixYears WhyWorkplaceWellnessProgramsAreWorthTheCost BacktoTop HomeHealthInsuranceAverageCostofCardiovascularDiseaseTreatmentinSingapore Singapore Korea India HongKong AboutUs Press Copyright©2022ValueChampion AdvertiserDisclosure:ValueChampionisafreesourceofinformationandtoolsforconsumers.Oursitemaynotfeatureeverycompanyorfinancialproductavailableonthemarket.However,theguidesandtoolswecreatearebasedonobjectiveandindependentanalysissothattheycanhelpeveryonemakefinancialdecisionswithconfidence.SomeoftheoffersthatappearonthiswebsitearefromcompanieswhichValueChampionreceivescompensation.Thiscompensationmayimpacthowandwhereoffersappearonthissite(including,forexample,theorderinwhichtheyappear).However,thisdoesnotaffectourrecommendationsoradvice,whicharegroundedinthousandsofhoursofresearch.Ourpartnerscannotpayustoguaranteefavorablereviewsoftheirproductsorservices Westrivetohavethemostcurrentinformationonoursite,butconsumersshouldinquirewiththerelevantfinancialinstitutioniftheyhaveanyquestions,includingeligibilitytobuyfinancialproducts.ValueChampionisnottobeconstruedasinanywayengagingorbeinginvolvedinthedistributionorsaleofanyfinancialproductorassuminganyriskorundertakinganyliabilityinrespectofanyfinancialproduct.Thesitedoesnotrevieworincludeallcompaniesorallavailableproducts.